Xeris Biopharma Holdings Inc
XERS7.370USD
+0.160+2.22%
Close 12/26, 16:00（ET）Quotes delayed by 15 min
1.22BMarket Cap
LossP/E TTM
Xeris Biopharma Holdings Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
203.07M
23.89%
EPS(YoY)
-0.37
17.38%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Xeris Biopharma Holdings Inc?
According to Xeris Biopharma Holdings Inc's FY2024 earnings report, its total revenue reached 203.07M, with a year-on-year change of 23.89%.
What is the Earnings Per Share (EPS) of Xeris Biopharma Holdings Inc?
According to Xeris Biopharma Holdings Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -0.374, with a year-on-year change of 17.38%.
What is the net income of Xeris Biopharma Holdings Inc?
According to Xeris Biopharma Holdings Inc's FY2024 earnings report, its net income was -54.84M, with a year-on-year change of 11.92%.
What is the net margin of Xeris Biopharma Holdings Inc?
According to Xeris Biopharma Holdings Inc's FY2024 earnings report, its net profit margin was -27.00%, with a year-on-year change of 28.90%.
What is the gross margin of Xeris Biopharma Holdings Inc?
According to Xeris Biopharma Holdings Inc's FY2024 earnings report, its gross margin was 76.52%, with a year-on-year change of 0.81%.
What is the debt-to-asset ratio of Xeris Biopharma Holdings Inc?
According to Xeris Biopharma Holdings Inc's FY2024 earnings report, its debt-to-asset ratio was 71.85%, with a year-on-year change of 21.39%.
What is the Return on Equity (ROE) of Xeris Biopharma Holdings Inc?
According to Xeris Biopharma Holdings Inc's FY2024 earnings report, its Return on Equity (ROE) was --, with a year-on-year change of --.
What is the Return on Assets (ROA) of Xeris Biopharma Holdings Inc?
According to Xeris Biopharma Holdings Inc's FY2024 earnings report, its Return on Assets (ROA) was -16.99%, with a year-on-year change of 8.99%.
What is the operating profit of Xeris Biopharma Holdings Inc?
According to Xeris Biopharma Holdings Inc's FY2024 earnings report, its operating profit was -33.65M, with a year-on-year change of 23.55%.
What are the current assets of Xeris Biopharma Holdings Inc?
According to Xeris Biopharma Holdings Inc's FY2024 earnings report, its current assets were 167.66M, with a year-on-year change of 7.29%.
What are the total assets of Xeris Biopharma Holdings Inc?
According to Xeris Biopharma Holdings Inc's FY2024 earnings report, its total assets of Xeris Biopharma Holdings Inc were 323.06M, with a year-on-year change of 0.14%.
What are the total liabilities of Xeris Biopharma Holdings Inc?
According to Xeris Biopharma Holdings Inc's FY2024 earnings report, its total liabilities of Xeris Biopharma Holdings Inc were 352.68M, with a year-on-year change of 7.07%.
What is the total equity of Xeris Biopharma Holdings Inc?
According to Xeris Biopharma Holdings Inc's FY2024 earnings report, its total equity of Xeris Biopharma Holdings Inc was -29.61M, with a year-on-year change of -336.67%.
What is the net operating income of Xeris Biopharma Holdings Inc?
According to Xeris Biopharma Holdings Inc's FY2024 earnings report, its net operating income of Xeris Biopharma Holdings Inc was -54.84M, with a year-on-year change of 11.92%.
What is the net investment of Xeris Biopharma Holdings Inc?
According to Xeris Biopharma Holdings Inc's FY2024 earnings report, its net investment of Xeris Biopharma Holdings Inc was 4.88M, with a year-on-year change of 181.33%.
What is the net financing of Xeris Biopharma Holdings Inc?
According to Xeris Biopharma Holdings Inc's FY2024 earnings report, its net financing of Xeris Biopharma Holdings Inc was 36.17M, with a year-on-year change of 2342.28%.
